Rightslink® by Copyright Clearance Center

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial

Author:

Jonas Bergh,Tom Wiklund,Björn Erikstein,Elisabet Lidbrink,Henrik Lindman,Per Malmström,Pirkko Kellokumpu-Lehtinen,Nils-Olof Bengtsson,Gustaf Söderlund,Gun Anker,Erik Wist,Susanne Ottosson,Eeva Salminen,Per Ljungman,Harald Holte,Jonas Nilsson et al.

Publication:

The Lancet

Publisher:

Elsevier

Date:

21 October 2000

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Welcome to RightsLink

has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing this content.

I would like to...No help available.